arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Ginkgo Bioworks Holdings, Inc.

DNA

$7.96 ▼ -0.53 (-6.24%) at close

7 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Ginkgo Bioworks Holdings, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $441.4M

Dividend Yield —

Revenue Growth -25.1% ↘

Op. Margin -185.3% ↗

ROIC -61.8% ↗

FCF / Share $-3.22 ↗

Trailing P/E —

Price / Book 0.9x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$170.16M

↓ -25.1% —

Net Income Profit after all expenses

$-312.76M

↑ +42.8% —

Operating Margin Operating profit as % of sales

-185.3%

↑ +24.8% 0th

FCF / Share Free cash flow per share

$-3.22

↑ +56.2% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns ↓

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	-25.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-413%)	-9.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-221%)	-47.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-692%)	52.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+553%)	309.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3768%)	41.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+418%)	—
EPS Growth YoY (%)	46.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	42.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	63.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	7.4% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-1250.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	—
Net Income Growth YoY (%)	42.8% Excellent ↑ Excellent Improving Year-over-year change in net income	38.7% Excellent ↑ Excellent Improving Year-over-year change in net income	57.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-15.0% Weak ↑ Weak Improving Year-over-year change in net income	-1345.4% Weak Weak Year-over-year change in net income	-6.1% Weak Weak Year-over-year change in net income	—
FCF Growth YoY (%)	56.2% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-6.4% Weak ↑ Weak Improving Year-over-year change in free cash flow	4.6% Caution ↑ Caution Improving Year-over-year change in free cash flow	20.5% Good ↑ Good Improving Year-over-year change in free cash flow	-50.2% Weak Weak Year-over-year change in free cash flow	-161.0% Weak Weak Year-over-year change in free cash flow	—
Revenue CAGR 3Y (%)	-29.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-10.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	48.6% Excellent Excellent Compound annual revenue growth over 3 years	106.6% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—
Revenue CAGR 5Y (%)	17.3% Excellent Excellent Compound annual revenue growth over 5 years	33.2% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	-185.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1335%)	-246.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1744%)	-343.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2392%)	-462.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3183%)	—	-178.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1292%)	-132.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-981%)
Effective Tax Rate (%) (%)	0.3% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.7% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.5% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%
Profit Margin (%) (%)	-183.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1632%)	-240.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2108%)	-355.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3059%)	-440.6% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3772%)	—	-165.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1476%)	-220.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1935%)
FCF Margin (%) (%)	-105.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-168.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-133.7% Weak → Weak Stable Free cash flow as a percentage of revenue Optimal: > 10%	-63.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-98.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-252.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-123.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%
FCF / Net Income (x)	0.57x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.70x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.38x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.14x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.17x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.53x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak Weak Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-61.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-78.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	—	-126.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-121.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-30.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-28.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-40.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-51.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-87.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-88.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-20.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-61.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-510%)	-76.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-609%)	—	-121.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-908%)	-121.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-910%)	-27.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-283%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Interest Coverage (x)	-78819.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-17492.41x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-9294.69x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-20839.17x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-770.53x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-57.45x Weak Weak Operating income divided by interest expense Optimal: > 5x	-29.57x Weak Weak Operating income divided by interest expense Optimal: > 5x
Net Debt (USD)	$-167.20M	$-561.57M	$-944.07M	$-1.32B	$-1.55B	$-380.80M	$-495.29M

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$3.07	$4.38	$5.17	$11.38	$9.23	$2.41	$1.89
Basic EPS, GAAP (USD)	$-5.64	$-10.54	$-18.40	$-50.00	$-54.00	$-4.00	$-4.00
Free Cash Flow per Share (USD)	$-3.22	$-7.36	$-6.92	$-7.25	$-9.13	$-6.08	$-2.33
Book Value per Share (USD)	$8.74	$13.17	—	$36.71	$37.37	$14.32	—
Tangible Book Value per Share (USD)	$7.76	$11.84	—	$33.09	$36.30	$14.16	—
Basic Weighted Avg Shares (shares)	55.46M	51.89M	48.61M	41.98M	34.00M	31.87M	28.73M

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$375.87M	$495.48M	$837.89M	$1.28B	$1.59B	$353.32M	—
Total Equity (USD)	$508.59M	$716.06M	—	$1.74B	$1.51B	$461.38M	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$170.16M	$227.04M	$251.46M	$477.71M	$313.84M	$76.66M	$54.18M
Depreciation Expense (USD)	$40.30M	$45.00M	$54.80M	$36.90M	$26.90M	$12.60M	$9.60M
Net Income, GAAP (USD)	$-312.76M	$-547.03M	$-892.87M	$-2.10B	$-1.83B	$-126.61M	$-119.33M
Operating Cash Flow (USD)	$-171.06M	$-319.58M	$-295.50M	$-252.20M	$-253.82M	$-135.83M	$-44.66M

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 24 quarters

Ginkgo Bioworks Holdings, Inc.

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare DNA with peers